Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 45 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: Comparison of different mouse strainsLiu, L.; Coller, J.; Watkins, L.; Somogyi, A.; Hutchinson, M.
2012Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in miceWu, Y.; Lousberg, E.; Moldenhauer, L.; Hayball, J.; Coller, J.; Rice, K.; Watkins, L.; Somogyi, A.; Hutchinson, M.
20113,4-Methylenedioxymethamphetamine (MDMA) induced hyperthermia - the role of pro-inflammatory cytokinesSalem, A.; Gordon, J.; Hutchinson, M.; Irvine, R.
2012Morphine activates neuroinflammation in a manner parallel to endotoxinWang, X.; Loram, L.; Ramos, K.; de Jesus, A.; Thomas, J.; Cheng, K.; Reddy, A.; Somogyi, A.; Hutchinson, M.; Watkins, L.; Yin, H.
2009The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine releaseBland, S.; Hutchinson, M.; Maier, S.; Watkins, L.; Johnson, K.
2010Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequencesHutchinson, M.; Lewis, S.; Coats, B.; Rezvani, N.; Zhang, Y.; Wieseler, J.; Somogyi, A.; Yin, H.; Maier, S.; Rice, K.; Watkins, L.
2013Medication-overuse headache and opioid-induced hyperalgesia: A review of mechanisms, a neuroimmune hypothesis and a novel approach to treatmentJohnson, J.; Hutchinson, M.; Williams, D.; Rolan, P.
2010Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activityHutchinson, M.; Loram, L.; Zhang, Y.; Shridhar, M.; Rezvani, N.; Berkelhammer, D.; Phipps, S.; Foster, P.; Landgraf, K.; Falke, J.; Rice, K.; Maier, S.; Yin, H.; Watkins, L.
2010Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1betaLewis, S.; Hutchinson, M.; Rezvani, N.; Loram, L.; Zhang, Y.; Maier, S.; Rice, K.; Watkins, L.
2009Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological diseaseRolan, P.; Hutchinson, M.; Johnson, K.